Haisco Pharmaceutical Group Co., Ltd.

SZSE:002653.SZ

23.19 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

20242023202220212020201920182017201620152014201320122011201020092008
Operating Activities:
Net Income 466.2295.563391.644517.582601.205474.85317.542229.104452.647372.158450.541519.219443.061312.296305.753283.719195.087
Depreciation & Amortization 249.217219.584184.123153.188104.58587.92972.15663.15961.47552.80642.65626.43121.21118.58511.1158.9575.322
Deferred Income Tax 0-20.524-41.251-3.18965.762-33.476-56.489-32.152-14.0392.5850000000
Stock Based Compensation 008.4580.6769.1335.25600000000000
Change In Working Capital -283.936-377.753-327.149-350.346-430.124149.8480.027134.504-28.40772.48558.51529.66711.7-74.16646.46276.628-110.139
Accounts Receivables -182.983-70.942-191.108-45.8816.126160.824-254.079-273.004-182.55240.647-18.052-11.276-39.8440000
Inventory 10.81866.193-90.384-36.288-39.087-40.568-7.43-26.053-43.186-11.649-4.339-32.385-4.794-7.34718.478-24.329-10.159
Accounts Payables 0-352.48-4.407-264.989-472.92563.067318.024465.712210.95340.9020000000
Other Working Capital -111.771-20.524-41.251-3.18965.762-33.4767.456160.55614.77984.13462.85462.05216.495-66.81927.985100.957-99.98
Other Non Cash Items 10.565332.709-121.28-282.109-144.35379.85282.883-34.955-59.603-54.421-49.144-6.902-11.2214.0784.051-1.094.175
Operating Cash Flow 442.046449.57894.54635.801206.208764.26472.607391.811426.112443.028502.568568.415464.752260.794367.381368.21494.445
Investing Activities:
Investments In Property Plant And Equipment -440.655-391.009-700.167-702.943-601.721-582.676-351.984-393.259-208.242-283.675-234.862-163.981-125.303-117.722-80.948-24.008-37.379
Acquisitions Net 0031.575180.163264.2550.56900.2541.8621.1340.0430.44911.280024.0080
Purchases Of Investments -2,400.133-820-170-1,740.598-1,345.176-541.365-1,040.283-1,780.772-331.693-1,250.066-1,835-665-198.500-17.50
Sales Maturities Of Investments 2,507.762823.528329.9272,545.0151,120.65546.524955.0551,943.344275.6011,525.1481,480.153140.53990.45000.4380
Other Investing Activites 31.4164.29-31.210.3332.80462.121192.2790.607275.842-201.928316.091110.709-726.1350.0850.534-24.0080.039
Investing Cash Flow -301.61-383.19-539.875281.97-559.188-514.826-244.934-229.82613.37-209.388-273.574-577.284-948.207-117.637-80.414-41.071-37.341
Financing Activities:
Debt Repayment 85.509-288.026857.608115.56121.457145-117.908178.35188.701232.468170.312179.21949.343-20.5483.315-7.94-6.7
Common Stock Issued 006.3730-1.59000000000000
Common Stock Repurchased 0-8.162-6.373-2.469-0.956000-87.756-112.1360000000
Dividends Paid -422.042-42.574-199.187-399.706-98.775-203.226-325.89-510.39-286.488-230.508-281.651-303.431-240.787-0.954-122.217-281.834-1.715
Other Financing Activities 85.857658.667-12.729125.88325.24-11.876-2.815.931-48.869-108.066-9.5728.395736.3971.58287.0536.840.27
Financing Cash Flow -250.676328.066624.23-187.234-85.00628.898-446.598-316.109-175.769-106.106-109.328-115.816544.953-19.921-31.85-282.934-8.145
Other Information:
Effect Of Forex Changes On Cash 4.869-1.53816.942-6.769-1.7911.586-0.712-3.6866.8333.203-0.049000-0-00
Net Change In Cash -105.372392.917195.842123.768-439.778279.918-219.636-157.81270.546130.737119.617-124.68661.497123.236255.11744.20948.96
Cash At End Of Period 1,055.1281,160.499767.583571.74447.972887.75607.833827.469956.128685.583554.845435.228559.914498.417375.181120.06375.854